ZHAOKE OPHTH-B (06622.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov24

ZHAOGEOcular-B Receives Approval for PAN-90806 Ophthalmic Solution Clinical Trial Application

09:02

Nov6

ZHAOKE Ophthalmology Signs Distribution Agreement with PT Ferron Par Pharmaceuticals for BRIMOCHOL™ PF

09:46

Sep1

Zhaok 眼科's Core Drug Candidates Expected to be Approved for Market Entry Next Year

10:25

Zekewell Announces Interim Results, Anticipates Narrowing Losses, and Advances Multiple Product Development and Launch Plans

08:01

Aug28

ZHAOKE OPHTH-B released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 8.462 M, actual EPS HKD -0.1143

15:00

ZHAOKE Ophthalmology-B Reports Increased Loss in Mid-Year Earnings

11:28

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 8.648 M, Net Income -63.82 M, EPS -0.1168

Mar24

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 10.4 M, Net Income -86.01 M, EPS -0.1574

Aug29

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 26.74 M, Net Income -40.73 M, EPS -0.0752

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change